Cargando…

Deceased donor neutrophil gelatinase-associated lipocalin and delayed graft function after kidney transplantation: a prospective study

INTRODUCTION: Expanding the criteria for deceased organ donors increases the risk of delayed graft function (DGF) and complicates kidney transplant outcome. We studied whether donor neutrophil gelatinase-associated lipocalin (NGAL), a novel biomarker for acute kidney injury, could predict DGF after...

Descripción completa

Detalles Bibliográficos
Autores principales: Hollmen, Maria E, Kyllönen, Lauri E, Inkinen, Kaija A, Lalla, Martti LT, Merenmies, Jussi, Salmela, Kaija T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218974/
https://www.ncbi.nlm.nih.gov/pubmed/21545740
http://dx.doi.org/10.1186/cc10220
_version_ 1782216770024636416
author Hollmen, Maria E
Kyllönen, Lauri E
Inkinen, Kaija A
Lalla, Martti LT
Merenmies, Jussi
Salmela, Kaija T
author_facet Hollmen, Maria E
Kyllönen, Lauri E
Inkinen, Kaija A
Lalla, Martti LT
Merenmies, Jussi
Salmela, Kaija T
author_sort Hollmen, Maria E
collection PubMed
description INTRODUCTION: Expanding the criteria for deceased organ donors increases the risk of delayed graft function (DGF) and complicates kidney transplant outcome. We studied whether donor neutrophil gelatinase-associated lipocalin (NGAL), a novel biomarker for acute kidney injury, could predict DGF after transplantation. METHODS: We included 99 consecutive, deceased donors and their 176 kidney recipients. For NGAL detection, donor serum and urine samples were collected before the donor operation. The samples were analyzed using a commercial enzyme-linked immunosorbent assay kit (serum) and the ARCHITECT method (urine). RESULTS: Mean donor serum NGAL (S-NGAL) concentration was 218 ng/mL (range 27 to 658, standard deviation (SD) 145.1) and mean donor urine NGAL (U-NGAL) concentration was 18 ng/mL (range 0 to 177, SD 27.1). Donor S-NGAL and U-NGAL concentrations correlated directly with donor plasma creatinine levels and indirectly with estimated glomerular filtration rate (eGFR) calculated using the modification of diet in renal disease equation for glomerular filtration rate. In transplantations with high (greater than the mean) donor U-NGAL concentrations, prolonged DGF lasting longer than 14 days occurred more often than in transplantations with low (less than the mean) U-NGAL concentration (23% vs. 11%, P = 0.028), and 1-year graft survival was worse (90.3% vs. 97.4%, P = 0.048). High U-NGAL concentration was also associated with significantly more histological changes in the donor kidney biopsies than the low U-NGAL concentration. In a multivariate analysis, U-NGAL, expanded criteria donor status and eGFR emerged as independent risk factors for prolonged DGF. U-NGAL concentration failed to predict DGF on the basis of receiver operating characteristic curve analysis. CONCLUSIONS: This first report on S-NGAL and U-NGAL levels in deceased donors shows that donor U-NGAL, but not donor S-NGAL, measurements give added value when evaluating the suitability of a potential deceased kidney donor.
format Online
Article
Text
id pubmed-3218974
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32189742011-11-17 Deceased donor neutrophil gelatinase-associated lipocalin and delayed graft function after kidney transplantation: a prospective study Hollmen, Maria E Kyllönen, Lauri E Inkinen, Kaija A Lalla, Martti LT Merenmies, Jussi Salmela, Kaija T Crit Care Research INTRODUCTION: Expanding the criteria for deceased organ donors increases the risk of delayed graft function (DGF) and complicates kidney transplant outcome. We studied whether donor neutrophil gelatinase-associated lipocalin (NGAL), a novel biomarker for acute kidney injury, could predict DGF after transplantation. METHODS: We included 99 consecutive, deceased donors and their 176 kidney recipients. For NGAL detection, donor serum and urine samples were collected before the donor operation. The samples were analyzed using a commercial enzyme-linked immunosorbent assay kit (serum) and the ARCHITECT method (urine). RESULTS: Mean donor serum NGAL (S-NGAL) concentration was 218 ng/mL (range 27 to 658, standard deviation (SD) 145.1) and mean donor urine NGAL (U-NGAL) concentration was 18 ng/mL (range 0 to 177, SD 27.1). Donor S-NGAL and U-NGAL concentrations correlated directly with donor plasma creatinine levels and indirectly with estimated glomerular filtration rate (eGFR) calculated using the modification of diet in renal disease equation for glomerular filtration rate. In transplantations with high (greater than the mean) donor U-NGAL concentrations, prolonged DGF lasting longer than 14 days occurred more often than in transplantations with low (less than the mean) U-NGAL concentration (23% vs. 11%, P = 0.028), and 1-year graft survival was worse (90.3% vs. 97.4%, P = 0.048). High U-NGAL concentration was also associated with significantly more histological changes in the donor kidney biopsies than the low U-NGAL concentration. In a multivariate analysis, U-NGAL, expanded criteria donor status and eGFR emerged as independent risk factors for prolonged DGF. U-NGAL concentration failed to predict DGF on the basis of receiver operating characteristic curve analysis. CONCLUSIONS: This first report on S-NGAL and U-NGAL levels in deceased donors shows that donor U-NGAL, but not donor S-NGAL, measurements give added value when evaluating the suitability of a potential deceased kidney donor. BioMed Central 2011 2011-05-05 /pmc/articles/PMC3218974/ /pubmed/21545740 http://dx.doi.org/10.1186/cc10220 Text en Copyright ©2011 Hollmen et al.; licensee BioMed Central Ltd http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
spellingShingle Research
Hollmen, Maria E
Kyllönen, Lauri E
Inkinen, Kaija A
Lalla, Martti LT
Merenmies, Jussi
Salmela, Kaija T
Deceased donor neutrophil gelatinase-associated lipocalin and delayed graft function after kidney transplantation: a prospective study
title Deceased donor neutrophil gelatinase-associated lipocalin and delayed graft function after kidney transplantation: a prospective study
title_full Deceased donor neutrophil gelatinase-associated lipocalin and delayed graft function after kidney transplantation: a prospective study
title_fullStr Deceased donor neutrophil gelatinase-associated lipocalin and delayed graft function after kidney transplantation: a prospective study
title_full_unstemmed Deceased donor neutrophil gelatinase-associated lipocalin and delayed graft function after kidney transplantation: a prospective study
title_short Deceased donor neutrophil gelatinase-associated lipocalin and delayed graft function after kidney transplantation: a prospective study
title_sort deceased donor neutrophil gelatinase-associated lipocalin and delayed graft function after kidney transplantation: a prospective study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218974/
https://www.ncbi.nlm.nih.gov/pubmed/21545740
http://dx.doi.org/10.1186/cc10220
work_keys_str_mv AT hollmenmariae deceaseddonorneutrophilgelatinaseassociatedlipocalinanddelayedgraftfunctionafterkidneytransplantationaprospectivestudy
AT kyllonenlaurie deceaseddonorneutrophilgelatinaseassociatedlipocalinanddelayedgraftfunctionafterkidneytransplantationaprospectivestudy
AT inkinenkaijaa deceaseddonorneutrophilgelatinaseassociatedlipocalinanddelayedgraftfunctionafterkidneytransplantationaprospectivestudy
AT lallamarttilt deceaseddonorneutrophilgelatinaseassociatedlipocalinanddelayedgraftfunctionafterkidneytransplantationaprospectivestudy
AT merenmiesjussi deceaseddonorneutrophilgelatinaseassociatedlipocalinanddelayedgraftfunctionafterkidneytransplantationaprospectivestudy
AT salmelakaijat deceaseddonorneutrophilgelatinaseassociatedlipocalinanddelayedgraftfunctionafterkidneytransplantationaprospectivestudy